Sandip Kapadia named CFO and CAO; 150k RSUs granted to Kapadia and Dierks

Harmony Biosciences Holdings, Inc.

Sandip Kapadia appointed CFO and Chief Administrative Officer effective Sep 30, 2023.
Kapadia receives 150,000 RSUs vesting 40% year 1, 30% year 2, 30% year 3.
Chief Commercial Officer Jeffrey Dierks also receives 150,000 RSUs on same vesting schedule.
Unvested RSUs accelerate on termination without cause (subject to release).
Both awards are retention grants under the 2020 Incentive Award Plan.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Sandip Kapadia

Chief Financial Officer and Chief Administrative Officer

HRMY · Harmony Biosciences Holdings, Inc.

Effective: 2023-09-30
Filed: October 5, 2023, 7:59 PM ET

The Board of Directors of Harmony Biosciences Holdings, Inc. (the “Company”) appointed Sandip Kapadia, the Company’s Chief Financial Officer, to the title of Chief Financial Officer and Chief Administrative Officer, effective upon Mr. Kapadia’s acceptance on September 30, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sandip Kapadia was appointed as Chief Financial Officer and Chief Administrative Officer at Harmony Biosciences Holdings, Inc..

Action: appointed
Role: Chief Financial Officer and Chief Administrative Officer

Exact text from the filing

The Board of Directors of Harmony Biosciences Holdings, Inc. (the “Company”) appointed Sandip Kapadia, the Company’s Chief Financial Officer, to the title of Chief Financial Officer and Chief Administrative Officer, effective upon Mr. Kapadia’s acceptance on September 30, 2023.

View on SEC.gov

Harmony Biosciences Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001558370-23-016259

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.